Filippo Acconcia

Filippo Acconcia

Oct 14, 2017

Group 6 Copy 95
0
    Please wait...

    About This Project

    70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Postpartum Mental Health Needs of Hispanic Mothers

    Postpartum mood disorders represent a critical public health issue affecting mothers and their children. Increased...

    MyHealthEd

    Each child deserves quality comprehensive sexual health education. No child is the same, so why should...

    Can Data Management Tools Improve Research Efficiency and Reproducibility?

    Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

    Campaign Ended